Bausch Health Companies Inc



+62.2% (1 year change)

Avg closing price

Price range

Market Cap

$9.95 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$14.86 - $34.80

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio


The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $9.95 Billion
Enterprise Value $33.3 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +62.2%
52-Week High $34.80
52-Week Low $14.86
Beta 1.23
Outstanding Shares 358 Million
Avg 30 Day Volume 3.19 Million


P/E Ratio -9.77
PEG -3.24
Earnings per Share -$2.86
Price to Sales Ratio 1.27
Price to Book Ratio 27.92
Revenue to Enterprise Value 4.14
EBIT to Enterprise Value 23.93
Total Debt to Enterprise Value 0.72
Debt to Equity 44.72


Revenue $8.04 Billion
Gross Profit $5.74 Billion
EBIT $1.39 Billion
Net Income -$1.02 Billion
Profit Margin -12.66%
Quarterly Earnings Growth (YoY) +301.3%
Return on Equity -190.28%
Return on Assets -3.26%
Return on Invested Capital 5.29%

Bausch Health Companies Inc

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.